Developer docs
API playgroundTry for free, no card

Search company profiles

Research To Prevent Blindness

Full company profile

uuid000f3ev

Namestring
Research To Prevent Blindness
Legal namestring
Research to Prevent Blindness
Websiteurl
rpbusa.org
Company typeenum
Private
Founded yearint
1960
Descriptiontext

Research to Prevent Blindness (RPB) is the leading U.S. nonprofit organization supporting vision research, founded in 1960 by Dr. Jules Stein and headquartered in New York City. RPB operates a two-pronged grant-making model that funds both individual vision researchers and departments of ophthalmology at U.S. academic medical centers, with annual grant disbursement of approximately $10-12 million and cumulative grants exceeding $441 million across 4,791 awards since inception.

RPB does not develop proprietary technology; rather, its 'product' is a structured portfolio of grant programs spanning the career pipeline from medical students ($30,000 fellowships) through early-career faculty ($350,000 Career Development Awards and $150,000 Career Advancement Awards) to established investigators ($300,000 Stein Innovation Awards, $300,000 Physician-Scientist Awards) and departmental grants ($150,000/year Unrestricted Grants and $360,000 Challenge Grants). Specialty awards target specific diseases including AMD, glaucoma, amblyopia, diabetic retinal disease, and ocular cancer, often via co-funding partnerships with medical associations (AAO, AUPO), disease-focused foundations (AMDF, IRRF, The Glaucoma Foundation), and corporate sponsors (Aerie Pharmaceuticals, Apellis, Johnson & Johnson, Castle Biosciences).

RPB's business model is IRS-recognized 501(c)(3) charitable fundraising (EIN #13-1945117) — it accepts tax-deductible donations from individuals, foundations, and corporate partners and disburses them as peer-reviewed grants across two annual cycles (spring and fall). Its primary customer segments are vision researchers at U.S. academic medical centers, departments of ophthalmology, and the patient/public audience for its educational resources (Learning Center, webinars). The organization maintains a small staff of 1-10 employees, with President Brian F. Hofland, PhD leading the organization. RPB is governed by a Scientific Advisory Panel and holds Charity Navigator 4-Star and GuideStar Platinum Transparency ratings.

Short descriptiontext

Research to Prevent Blindness is the leading U.S. nonprofit funding vision research, awarding ~$10-12M annually across individual researcher and departmental grants to U.S. academic medical centers; founded 1960, with $441M+ cumulative grants to date.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
vision research grants, ophthalmology research funding, medical research grants, nonprofit health research, eye disease research
Industry1 code
PRIMARYBPAGAKAL
Health & Medical Research Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
NAICS code2 codes
  • Grantmaking Foundations813211
  • Voluntary Health Organizations813212
SIC code1 code
  • Services-Health Services8000
Product category
Vision Research Grants / Nonprofit Medical Research Funding
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Donations and Charitable Contributions
TypeGrants Donations
Description

RPB is an IRS-recognized 501(c)(3) nonprofit organization (EIN #13-1945117) that raises funds from individual donors, foundations, and corporate partners to support vision research grants. The organization accepts both individual and organizational donations.

rpbusa.org
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Others, Personnel, Operations, Marketing or Sales
Pricing details5 tiers
1Medical Student Eye Research Fellowship: $30,000 for 1 year
ModelOtherBilling cadenceAnnual
Notes

$30,000 grant for medical students to conduct research in RPB-supported departments of ophthalmology. Additional $8,000 available for relocation assistance.

rpbusa.org
2Career Development Award: $350,000 for up to 4 years
ModelOtherBilling cadenceMulti-year contract
Notes

$350,000 payable for up to four years for early-career ophthalmology faculty at RPB-supported departments.

rpbusa.org
3Unrestricted Grant: $150,000 annually for 5 years
ModelOtherBilling cadenceAnnual
Notes

$150,000 annual grants for departments of ophthalmology with full-time permanent chairs at U.S. academic medical centers.

rpbusa.org
4Challenge Grant: $360,000 for up to 4 years
ModelOtherBilling cadenceMulti-year contract
Notes

$360,000 grants to emerging eye research programs and new department chairs, requiring medical school matching commitment.

rpbusa.org
5Stein Innovation Award: $300,000 for 3 years
ModelOtherBilling cadenceMulti-year contract
Notes

$300,000 seed money for high-risk/high-gain vision science research from researchers inside or outside ophthalmology departments.

rpbusa.org
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Research to Prevent Blindness is a nonprofit grant-making organization that funds vision science research in the United States. It operates a two-pronged grant model awarding individual researcher grants (Career Development, Career Advancement, Physician-Scientist, Stein Innovation, International Collaborators Awards and Medical Student Fellowships) and departmental grants (Unrestricted and Challenge Grants) to departments of ophthalmology at U.S. academic medical centers. RPB also supports patient and clinician education via the Learning Center and webinars, distributing roughly $10–12 million annually.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Nearly every major breakthrough in vision research has been associated with RPB funding since 1960
+3 more records
Product overview1 text field

Research to Prevent Blindness (RPB) operates as a nonprofit grants organization funding vision science research, not a traditional product company. Its offerings consist of a portfolio of grant programs and awards supporting researchers at various career stages, plus educational resources. The core grants portfolio includes individual researcher awards (Career Development Award, Career Advancement Award, Physician-Scientist Award, Stein Innovation Award, International Research Collaborators Award) and departmental grants (Unrestricted Grant, Challenge Grant). Specialty awards target specific diseases (Catalyst Award for AMD, Disney Award for Amblyopia, glaucoma-focused awards with Aerie Pharmaceuticals and TGF) and populations (Medical Student Fellowships). RPB also maintains the Learning Center providing patient education and hosts webinars. Total annual grant funding is approximately $10-12 million.

Product and service19 records
1RPB Career Development Award
CategoryIndividual Researcher Grant
Description

$350,000 over up to four years supporting early-career ophthalmology faculty at RPB-supported departments to launch independent research careers.

2RPB Career Advancement Award
CategoryIndividual Researcher Grant
Description

$150,000 one-time award for outstanding early-career vision scientists who have received their first NIH R01 and are collecting data for a second R01.

3RPB Unrestricted Grant
CategoryDepartmental Grant
Description

$150,000 annual grant, renewed annually for up to five years, providing maximum flexibility to ophthalmology departments at U.S. academic medical centers.

4RPB Challenge Grant
CategoryDepartmental Grant
Description

$360,000 four-year departmental grant encouraging growth for emerging eye research programs and newly appointed department chairs, requiring medical school matching commitment.

5RPB Physician-Scientist Award
CategoryIndividual Researcher Grant
Description

$300,000 award promoting clinical, translational, and basic science research of clinician researchers (MDs or MD/PhDs) at RPB-supported departments.

6RPB Stein Innovation Award
CategoryIndividual Researcher Grant
Description

$300,000 seed award over three years for high-risk/high-gain vision science research from researchers inside or outside ophthalmology departments.

7RPB International Research Collaborators Award
CategoryIndividual Researcher Grant
Description

$75,000 award promoting international collaborations where U.S. and international researchers exchange knowledge and skills through reciprocal research visits.

8RPB Medical Student Eye Research Fellowship
CategoryFellowship
Description

$30,000 one-year fellowship allowing medical students to conduct research in RPB-supported ophthalmology departments, with additional $8,000 available for relocation assistance.

9RPB Catalyst Award for Innovative Research Approaches for AMD
CategoryDisease-Specific Grant
Description

$300,000 co-funded award with the American Macular Degeneration Foundation, Dr. H. James and Carole Free, and the International Retinal Research Foundation supporting novel approaches to understanding or treating age-related macular degeneration.

10RPB Walt and Lilly Disney Award for Amblyopia Research
CategoryDisease-Specific Grant
Description

Award supporting exceptional researchers doing significant work in amblyopia pathophysiology, diagnosis, and/or treatment.

11RPB Transformational Team Science Award
CategoryTeam Science Grant
Description

New $950,000 large-scale team science grant program; inaugural award funds the Eyewire II consortium creating the first fully-mapped region of the mammalian central nervous system (mouse retina connectome).

12RPB / Tom Wertheimer Career Development Award in Data Science
CategoryIndividual Researcher Grant
Description

$350,000 specialized Career Development Award over four years for vision research using artificial intelligence and data science for sight-threatening conditions.

13RPB / Mary Tyler Moore Vision Initiative Physician-Scientist Award
CategoryDisease-Specific Grant
Description

$300,000 partnership award focused on retinal research for diabetic retinopathy, diabetic macular edema, and diabetic retinal neurodegeneration.

14RPB / AAO Award for IRIS Registry Research
CategoryDisease-Specific Grant
Description

Partnership award with the American Academy of Ophthalmology providing $35,000 plus database access and training for big data eye disease research using the IRIS Registry (70+ million patients).

15RPB / David L. Epstein Career Advancement Award in Glaucoma Research
CategoryDisease-Specific Grant
Description

$150,000 partnership award with Aerie Pharmaceuticals for outstanding early-career glaucoma researchers who have received their first NIH R01 and are collecting data for a second R01.

16RPB / TGF Glaucoma Fellowship
CategoryFellowship
Description

Partnership fellowship co-funded with The Glaucoma Foundation for medical students conducting glaucoma research, administered by The Glaucoma Foundation.

17RPB David F. Weeks Award for Outstanding Vision Research
CategoryAnnual Recognition Award
Description

Prestigious annual award funded by RPB, an anonymous donor, and the Association of University Professors of Ophthalmology, recognizing an excellent vision researcher each year in honor of former RPB President David F. Weeks.

18RPB Learning Center
CategoryEducational Resource
Description

Online educational resource providing patients and families with information about eye anatomy, common eye diseases, and disease directories covering dry eye, glaucoma, AMD, diabetic retinal disease, and more.

19RPB Webinars and Videos
CategoryEducational Resource
Description

Educational video content including the Lunch & Learn webinar series covering diabetic retinopathy, low vision, ocular genetics, glaucoma, age-related macular degeneration, and Stargardt disease.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-04-22
Description

RPB awarded $950,000 Transformational Team Science Award to Eyewire II project creating the first fully-mapped region of the mammalian central nervous system (mouse retina connectome). The project combines functional calcium imaging and 3D electron microscopy to create complete wiring diagrams. Funding goes to Northwestern University which disperses to international team members including researchers from Princeton University and University of Tübingen.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-04-22
Description

Co-funding partner for Catalyst Awards for Innovative Research Approaches for AMD. One award of $300,000 given through this partnership.

3Dr. H. James and Carole Free
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-04-22
Description

Co-funding partner for Catalyst Awards for Innovative Research Approaches for AMD. One award of $300,000 given through this partnership (pending funding).

rpbusa.org
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-04-22
Description

Co-funding partner for Catalyst Awards for Innovative Research Approaches for AMD. One award of $300,000 given through this partnership.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-04-22
Description

Co-funding partnership for medical student fellowship focused on glaucoma research. The TGF/RPB Glaucoma Fellowships are administered by The Glaucoma Foundation.

6Vision Research Funding Partnership Sponsors
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2025-03-25
Description

Event sponsors for Vision Research Funding Partnership 2025 including Visionary Sponsor Apellis Pharmaceuticals; Gold Sponsors AAO, Johnson & Johnson, Mary Tyler Moore Vision Initiative; Silver Sponsors Alkeus, All May See, Glaucoma Research Foundation, Prevent Blindness, Topcon Healthcare; Bronze Sponsors American Macular Degeneration Foundation, ARVO, EyeSight Foundation of Alabama, International Retinal Research Foundation.

rpbusa.org
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-08
Description

Annual co-funding partnership for the RPB David F. Weeks Award for Outstanding Vision Research. AUPO is a nonprofit dedicated to research and education in academic ophthalmology, founded in 1966.

8American Academy of Ophthalmology (AAO)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-08-20
Description

Partnership since 2018 for the RPB/AAO Award for IRIS Registry Research, leveraging the IRIS Registry database of 70+ million patients to answer pressing questions about eye diseases. Recipients receive database access and $10,000 in research funds plus $35,000 total award.

rpbusa.org
9Mary Tyler Moore Vision Initiative
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-04-24
Description

Co-funding partnership for the Physician-Scientist Award focused on diabetic retinal disease research. Initiative founded by Dr. S. Robert Levine to end vision loss from diabetes following his wife Mary Tyler Moore's condition.

rpbusa.org
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-05-16
Description

Partnership to fund the RPB/David L. Epstein Career Advancement Award in Glaucoma Research sponsored by Aerie Pharmaceuticals. Two awards of $150,000 each for researchers who have received their first NIH R01 and are collecting data for a second R01.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

The leading U.S. nonprofit funding retinal degenerative disease research, with similar mission, donor-funded grantmaking model, and grantee ecosystem. Directly comparable as another vision-specific private grantmaking foundation.

TypeDirect peer
Description

Funds research on macular degeneration, glaucoma, and Alzheimer's through grants to academic researchers. Comparable donor-funded grantmaking model focused on vision (and adjacent neurodegenerative) disease research.

TypeDirect peer
Description

U.S. nonprofit funding glaucoma-specific research through grants to academic medical centers. Directly comparable mission overlap and donor-funded grantmaking structure; co-funds some RPB programs including medical student fellowships.

TypeDirect peer
Description

U.S. nonprofit focused on vision health through advocacy, education, and research support. Comparable mission and donor base; participates in RPB's Vision Research Funding Partnership. Overlapping focus on vision research funding and public education.

TypeDirect peer
Description

U.S. nonprofit specifically funding age-related macular degeneration research and patient education. Co-funds RPB's Catalyst Award for AMD, evidencing direct operational overlap in vision research grantmaking.

TypeDirect peer
Description

Nonprofit funding retinal disease research, co-funding partner with RPB on the Catalyst Award for AMD. Directly comparable grantmaking model focused on vision research.

TypeBroad incumbent
Description

The U.S. federal government's primary vision research funding agency. RPB helped establish NEI in 1968. NEI is a far larger public funder; both serve the same grantee ecosystem and have complementary catalytic roles.

TypeEmerging player
Description

Smaller nonprofit supporting vision and hearing research through grants. Overlapping mission in vision research funding but with a narrower programmatic portfolio than RPB.

9Knights Templar Eye Foundation
TypeEmerging player
Description

Charitable foundation funding pediatric vision research and ophthalmology education. Comparable donor-funded grantmaking model with a narrower (pediatric) focus than RPB.

10Mary Tyler Moore Vision Initiative
TypeEmerging player
Description

Nonprofit focused on diabetic retinal disease research co-founded by Dr. S. Robert Levine. Co-funds RPB's Physician-Scientist Award, evidencing direct operational overlap in vision research grantmaking with narrower disease focus.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Research To Prevent Blindness

Vision Research Grants / Nonprofit Medical Research Fundingrpbusa.org

Research to Prevent Blindness is the leading U.S. nonprofit funding vision research, awarding ~$10-12M annually across individual researcher and departmental grants to U.S. academic medical centers; founded 1960, with $441M+ cumulative grants to date.

What Research To Prevent Blindness does

Research to Prevent Blindness (RPB) is the leading U.S. nonprofit organization supporting vision research, founded in 1960 by Dr. Jules Stein and headquartered in New York City. RPB operates a two-pronged grant-making model that funds both individual vision researchers and departments of ophthalmology at U.S. academic medical centers, with annual grant disbursement of approximately $10-12 million and cumulative grants exceeding $441 million across 4,791 awards since inception.

RPB does not develop proprietary technology; rather, its 'product' is a structured portfolio of grant programs spanning the career pipeline from medical students ($30,000 fellowships) through early-career faculty ($350,000 Career Development Awards and $150,000 Career Advancement Awards) to established investigators ($300,000 Stein Innovation Awards, $300,000 Physician-Scientist Awards) and departmental grants ($150,000/year Unrestricted Grants and $360,000 Challenge Grants). Specialty awards target specific diseases including AMD, glaucoma, amblyopia, diabetic retinal disease, and ocular cancer, often via co-funding partnerships with medical associations (AAO, AUPO), disease-focused foundations (AMDF, IRRF, The Glaucoma Foundation), and corporate sponsors (Aerie Pharmaceuticals, Apellis, Johnson & Johnson, Castle Biosciences).

RPB's business model is IRS-recognized 501(c)(3) charitable fundraising (EIN #13-1945117) — it accepts tax-deductible donations from individuals, foundations, and corporate partners and disburses them as peer-reviewed grants across two annual cycles (spring and fall). Its primary customer segments are vision researchers at U.S. academic medical centers, departments of ophthalmology, and the patient/public audience for its educational resources (Learning Center, webinars). The organization maintains a small staff of 1-10 employees, with President Brian F. Hofland, PhD leading the organization. RPB is governed by a Scientific Advisory Panel and holds Charity Navigator 4-Star and GuideStar Platinum Transparency ratings.

Research To Prevent Blindness firmographics

Firmographics
Name
Research To Prevent Blindness
Legal name
Research to Prevent Blindness
Website
https://rpbusa.org
Company type
Private
Founded year
1960
Operating status
Operating
Headcount range
1–10 employees
Short description
Research to Prevent Blindness is the leading U.S. nonprofit funding vision research, awarding ~$10-12M annually across individual researcher and departmental grants to U.S. academic medical centers; founded 1960, with $441M+ cumulative grants to date.
Ownership category
akta.pro rank

Research To Prevent Blindness industry classification

Industry
Product category
Vision Research Grants / Nonprofit Medical Research Funding
NAICS
Grantmaking Foundations (813211), Voluntary Health Organizations (813212)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYBPAGAKAL
Health & Medical Research Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking

Keywords

  • Vision research grants
  • Ophthalmology research funding
  • Medical research grants
  • Nonprofit health research
  • Eye disease research

Where Research To Prevent Blindness is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Research To Prevent Blindness business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Others, Personnel, Operations, Marketing or Sales

Revenue model

  1. Donations and Charitable Contributions: RPB is an IRS-recognized 501(c)(3) nonprofit organization (EIN #13-1945117) that raises funds from individual donors, foundations, and corporate partners to support vision research grants. The organization accepts both individual and organizational donations.

Pricing tiers

ModelBillingPrice
OtherAnnualMedical Student Eye Research Fellowship: $30,000 for 1 year
OtherMulti-year contractCareer Development Award: $350,000 for up to 4 years
OtherAnnualUnrestricted Grant: $150,000 annually for 5 years
OtherMulti-year contractChallenge Grant: $360,000 for up to 4 years
OtherMulti-year contractStein Innovation Award: $300,000 for 3 years

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Research To Prevent Blindness product offering

Product offering

Core offering

Research to Prevent Blindness is a nonprofit grant-making organization that funds vision science research in the United States. It operates a two-pronged grant model awarding individual researcher grants (Career Development, Career Advancement, Physician-Scientist, Stein Innovation, International Collaborators Awards and Medical Student Fellowships) and departmental grants (Unrestricted and Challenge Grants) to departments of ophthalmology at U.S. academic medical centers. RPB also supports patient and clinician education via the Learning Center and webinars, distributing roughly $10–12 million annually.

Product overview

Research to Prevent Blindness (RPB) operates as a nonprofit grants organization funding vision science research, not a traditional product company. Its offerings consist of a portfolio of grant programs and awards supporting researchers at various career stages, plus educational resources. The core grants portfolio includes individual researcher awards (Career Development Award, Career Advancement Award, Physician-Scientist Award, Stein Innovation Award, International Research Collaborators Award) and departmental grants (Unrestricted Grant, Challenge Grant). Specialty awards target specific diseases (Catalyst Award for AMD, Disney Award for Amblyopia, glaucoma-focused awards with Aerie Pharmaceuticals and TGF) and populations (Medical Student Fellowships). RPB also maintains the Learning Center providing patient education and hosts webinars. Total annual grant funding is approximately $10-12 million.

Differentiator

Problem solved

Functional benefit

Products and services

  • RPB Career Development Award $350,000 over up to four years supporting early-career ophthalmology faculty at RPB-supported departments to launch independent research careers.
  • RPB Career Advancement Award $150,000 one-time award for outstanding early-career vision scientists who have received their first NIH R01 and are collecting data for a second R01.
  • RPB Unrestricted Grant $150,000 annual grant, renewed annually for up to five years, providing maximum flexibility to ophthalmology departments at U.S. academic medical centers.
  • RPB Challenge Grant $360,000 four-year departmental grant encouraging growth for emerging eye research programs and newly appointed department chairs, requiring medical school matching commitment.
  • RPB Physician-Scientist Award $300,000 award promoting clinical, translational, and basic science research of clinician researchers (MDs or MD/PhDs) at RPB-supported departments.
  • RPB Stein Innovation Award $300,000 seed award over three years for high-risk/high-gain vision science research from researchers inside or outside ophthalmology departments.
  • RPB International Research Collaborators Award $75,000 award promoting international collaborations where U.S. and international researchers exchange knowledge and skills through reciprocal research visits.
  • RPB Medical Student Eye Research Fellowship $30,000 one-year fellowship allowing medical students to conduct research in RPB-supported ophthalmology departments, with additional $8,000 available for relocation assistance.
  • RPB Catalyst Award for Innovative Research Approaches for AMD $300,000 co-funded award with the American Macular Degeneration Foundation, Dr. H. James and Carole Free, and the International Retinal Research Foundation supporting novel approaches to understanding or treating age-related macular degeneration.
  • RPB Walt and Lilly Disney Award for Amblyopia Research Award supporting exceptional researchers doing significant work in amblyopia pathophysiology, diagnosis, and/or treatment.
  • RPB Transformational Team Science Award New $950,000 large-scale team science grant program; inaugural award funds the Eyewire II consortium creating the first fully-mapped region of the mammalian central nervous system (mouse retina connectome).
  • RPB / Tom Wertheimer Career Development Award in Data Science $350,000 specialized Career Development Award over four years for vision research using artificial intelligence and data science for sight-threatening conditions.
  • RPB / Mary Tyler Moore Vision Initiative Physician-Scientist Award $300,000 partnership award focused on retinal research for diabetic retinopathy, diabetic macular edema, and diabetic retinal neurodegeneration.
  • RPB / AAO Award for IRIS Registry Research Partnership award with the American Academy of Ophthalmology providing $35,000 plus database access and training for big data eye disease research using the IRIS Registry (70+ million patients).
  • RPB / David L. Epstein Career Advancement Award in Glaucoma Research $150,000 partnership award with Aerie Pharmaceuticals for outstanding early-career glaucoma researchers who have received their first NIH R01 and are collecting data for a second R01.
  • RPB / TGF Glaucoma Fellowship Partnership fellowship co-funded with The Glaucoma Foundation for medical students conducting glaucoma research, administered by The Glaucoma Foundation.
  • RPB David F. Weeks Award for Outstanding Vision Research Prestigious annual award funded by RPB, an anonymous donor, and the Association of University Professors of Ophthalmology, recognizing an excellent vision researcher each year in honor of former RPB President David F. Weeks.
  • RPB Learning Center Online educational resource providing patients and families with information about eye anatomy, common eye diseases, and disease directories covering dry eye, glaucoma, AMD, diabetic retinal disease, and more.
  • RPB Webinars and Videos Educational video content including the Lunch & Learn webinar series covering diabetic retinopathy, low vision, ocular genetics, glaucoma, age-related macular degeneration, and Stargardt disease.

Quantifiable outcome

  • Nearly every major breakthrough in vision research has been associated with RPB funding since 1960
  • +3 more outcomes

Companies that use Research To Prevent Blindness

Customer profile

Named customers8 records

Segments3 records

Ideal customer profiles2 records

Research To Prevent Blindness technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Research To Prevent Blindness partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered flagship, core and minor.

  • Eyewire II ConsortiumflagshipStrategic or Co-development Partner · 22 April 2026RPB awarded $950,000 Transformational Team Science Award to Eyewire II project creating the first fully-mapped region of the mammalian central nervous system (mouse retina connectome). The project combines functional calcium imaging and 3D electron microscopy to create complete wiring diagrams. Funding goes to Northwestern University which disperses to international team members including researchers from Princeton University and University of Tübingen.
  • American Macular Degeneration FoundationcoreStrategic or Co-development Partner · 22 April 2025Co-funding partner for Catalyst Awards for Innovative Research Approaches for AMD. One award of $300,000 given through this partnership.
  • Dr. H. James and Carole FreecoreStrategic or Co-development Partner · 22 April 2025Co-funding partner for Catalyst Awards for Innovative Research Approaches for AMD. One award of $300,000 given through this partnership (pending funding).
  • International Retinal Research Foundation (IRRF)coreStrategic or Co-development Partner · 22 April 2025Co-funding partner for Catalyst Awards for Innovative Research Approaches for AMD. One award of $300,000 given through this partnership.
  • The Glaucoma FoundationcoreStrategic or Co-development Partner · 22 April 2025Co-funding partnership for medical student fellowship focused on glaucoma research. The TGF/RPB Glaucoma Fellowships are administered by The Glaucoma Foundation.
  • Vision Research Funding Partnership SponsorsminorGTM or Marketing Partner · 25 March 2025Event sponsors for Vision Research Funding Partnership 2025 including Visionary Sponsor Apellis Pharmaceuticals; Gold Sponsors AAO, Johnson & Johnson, Mary Tyler Moore Vision Initiative; Silver Sponsors Alkeus, All May See, Glaucoma Research Foundation, Prevent Blindness, Topcon Healthcare; Bronze Sponsors American Macular Degeneration Foundation, ARVO, EyeSight Foundation of Alabama, International Retinal Research Foundation.
  • Association of University Professors of Ophthalmology (AUPO)coreStrategic or Co-development Partner · 8 January 2025Annual co-funding partnership for the RPB David F. Weeks Award for Outstanding Vision Research. AUPO is a nonprofit dedicated to research and education in academic ophthalmology, founded in 1966.
  • American Academy of Ophthalmology (AAO)coreStrategic or Co-development Partner · 20 August 2024Partnership since 2018 for the RPB/AAO Award for IRIS Registry Research, leveraging the IRIS Registry database of 70+ million patients to answer pressing questions about eye diseases. Recipients receive database access and $10,000 in research funds plus $35,000 total award.
  • Mary Tyler Moore Vision InitiativecoreStrategic or Co-development Partner · 24 April 2023Co-funding partnership for the Physician-Scientist Award focused on diabetic retinal disease research. Initiative founded by Dr. S. Robert Levine to end vision loss from diabetes following his wife Mary Tyler Moore's condition.
  • Aerie PharmaceuticalscoreStrategic or Co-development Partner · 16 May 2022Partnership to fund the RPB/David L. Epstein Career Advancement Award in Glaucoma Research sponsored by Aerie Pharmaceuticals. Two awards of $150,000 each for researchers who have received their first NIH R01 and are collecting data for a second R01.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Research To Prevent Blindness competitors and assessment

Company assessment

Direct peers

  • Foundation Fighting Blindness: The leading U.S. nonprofit funding retinal degenerative disease research, with similar mission, donor-funded grantmaking model, and grantee ecosystem. Directly comparable as another vision-specific private grantmaking foundation.
  • BrightFocus Foundation: Funds research on macular degeneration, glaucoma, and Alzheimer's through grants to academic researchers. Comparable donor-funded grantmaking model focused on vision (and adjacent neurodegenerative) disease research.
  • Glaucoma Research Foundation: U.S. nonprofit funding glaucoma-specific research through grants to academic medical centers. Directly comparable mission overlap and donor-funded grantmaking structure; co-funds some RPB programs including medical student fellowships.
  • Prevent Blindness: U.S. nonprofit focused on vision health through advocacy, education, and research support. Comparable mission and donor base; participates in RPB's Vision Research Funding Partnership. Overlapping focus on vision research funding and public education.
  • American Macular Degeneration Foundation: U.S. nonprofit specifically funding age-related macular degeneration research and patient education. Co-funds RPB's Catalyst Award for AMD, evidencing direct operational overlap in vision research grantmaking.
  • International Retinal Research Foundation: Nonprofit funding retinal disease research, co-funding partner with RPB on the Catalyst Award for AMD. Directly comparable grantmaking model focused on vision research.

Broad incumbents

  • National Eye Institute (NEI): The U.S. federal government's primary vision research funding agency. RPB helped establish NEI in 1968. NEI is a far larger public funder; both serve the same grantee ecosystem and have complementary catalytic roles.

Emerging players

  • Helen Keller Foundation: Smaller nonprofit supporting vision and hearing research through grants. Overlapping mission in vision research funding but with a narrower programmatic portfolio than RPB.
  • Knights Templar Eye Foundation: Charitable foundation funding pediatric vision research and ophthalmology education. Comparable donor-funded grantmaking model with a narrower (pediatric) focus than RPB.
  • Mary Tyler Moore Vision Initiative: Nonprofit focused on diabetic retinal disease research co-founded by Dr. S. Robert Levine. Co-funds RPB's Physician-Scientist Award, evidencing direct operational overlap in vision research grantmaking with narrower disease focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Research To Prevent Blindness social profiles

Digital presence

Research To Prevent Blindness financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Research To Prevent Blindness leadership team

Management profile

Number of profiles

Profiles4 records

Research To Prevent Blindness funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Research To Prevent Blindness M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Research To Prevent Blindness

What does Research To Prevent Blindness do?

Research to Prevent Blindness is a nonprofit grant-making organization that funds vision science research in the United States. It operates a two-pronged grant model awarding individual researcher grants (Career Development, Career Advancement, Physician-Scientist, Stein Innovation, International Collaborators Awards and Medical Student Fellowships) and departmental grants (Unrestricted and Challenge Grants) to departments of ophthalmology at U.S. academic medical centers. RPB also supports patient and clinician education via the Learning Center and webinars, distributing roughly $10–12 million annually.

Is Research To Prevent Blindness a public or private company?

Research To Prevent Blindness is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Research To Prevent Blindness founded?

Research To Prevent Blindness was founded in 1960. It employs 1 to 10 people.

Where is Research To Prevent Blindness based?

Research To Prevent Blindness is headquartered in New York, United States, in the North America region.

How does Research To Prevent Blindness make money?

One revenue line is on record: donations and Charitable Contributions.

Who are Research To Prevent Blindness's main competitors?

Direct peers on record are Foundation Fighting Blindness, BrightFocus Foundation, Glaucoma Research Foundation, Prevent Blindness, American Macular Degeneration Foundation and International Retinal Research Foundation. National Eye Institute (NEI) is listed as a broad incumbent. Emerging players are Helen Keller Foundation, Knights Templar Eye Foundation and Mary Tyler Moore Vision Initiative.

Does Research To Prevent Blindness have an API?

No public API is recorded for Research To Prevent Blindness.

What industry is Research To Prevent Blindness in?

Research To Prevent Blindness's product category is Vision Research Grants / Nonprofit Medical Research Funding. Its primary akta.pro industry code is BPAGAKAL, Health & Medical Research Grantmaking Foundations. Its NAICS code is 813211 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
UscAI meets eye care in USC medical student Ryan Shean’s researchRyan Shean, a medical student at USC, is researching the application of artificial intelligence to improve glaucoma diagnosis and patient care. His work has earned him a fellowship from Research to Prevent Blindness, highlighting his potential in advancing eye care. The research aims to enhance diagnostic consistency and assist physicians in identifying the disease more effectively.Research to Prevent BlindnessRPB Hosts Vision Research Funding Partnership 2025Research to Prevent Blindness (RPB) convened over 30 organizations in Washington DC on March 25, 2025, for its tenth annual Vision Research Funding Partnership event. The meeting focused on the theme “Sight Across the Lifespan,” aiming to enhance collaboration among funders and stakeholders to support scientific research for eye diseases. Key topics included AI insights in ocular health, federal funding outlooks, and patient experience panels featuring representatives from various medical and advocacy groups.Research to Prevent BlindnessResearch to Prevent Blindness Opens Applications for Vision Research GrantsResearch to Prevent Blindness (RPB) has opened applications for its 2024 vision research grant cycle, offering approximately $11 million in annual funding across various categories including career development and innovation awards. The organization is partnering with entities such as Alcon, Johnson & Johnson, and the American Macular Degeneration Foundation to sponsor specific grants focused on areas like glaucoma, diabetic retinal disease, and age-related macular degeneration. Applications for individual researcher grants are due July 1, 2024, while nomination forms for departmental unrestricted grants are due June 15.Northwestern's McCormick School of EngineeringResearch to Prevent Blindness Grant Supports Department of OphthalmologyThe Department of Ophthalmology received a $115,000 annual grant from Research to Prevent Blindness for five years. The unrestricted funding supports investigators, young investigators, and new initiatives, and is awarded to only 30 departments. RPB has awarded over $4.75 million to Feinberg.YahooResearch to Prevent Blindness gives big boost to local instituteResearch to Prevent Blindness awarded the Dean McGee Eye Institute a grant of $115,000 per year for five years, one of only 30 such grants. The funds will support eye infection and disease research, including glaucoma and diabetic retinopathy, and allow for new equipment.GlobeNewswireDr. Kaustabh Ghosh Recognized With Prestigious Catalyst Award for Innovative Age-Related Macular Degeneration ResearchDr. Kaustabh Ghosh received the Catalyst Award from Research to Prevent Blindness and the International Retinal Research Foundation for innovative AMD research. The award provides a $300,000 grant to continue his work on vascular stiffness in early AMD. His multidisciplinary approach integrates physical, biological, and medical sciences.Northwestern's McCormick School of EngineeringGrant Provides Imaging Technology to Department of OphthalmologyThe Department of Ophthalmology received a Research to Prevent Blindness Challenge Grant to purchase imaging technology for research. The grant supports Jeremy Lavine's OCT imaging of mouse eyes and Benjamin Thomson's Heidelberg Spectralis system, enabling comparison with patient findings. Lavine's study identified macrophage-like cells at the vitreoretinal interface, suggesting an inflammatory biomarker for diabetic retinopathy.The Journal RecordOU Department of Ophthalmology earns grantThe University of Oklahoma Health Sciences Center received a five-year $575,000 grant from Research to Prevent Blindness to support eye research in its Department of Ophthalmology. The grant will fund studies on retinal degenerations, diabetic eye disease, and other conditions causing permanent vision loss. RPB has channeled over $397 million into eye research since 1960.Northwestern's McCormick School of EngineeringOphthalmology Receives Grant to Support International CollaborationSteven DeVries, MD, PhD, received a $75,000 grant from Research to Prevent Blindness to support international collaboration on growing 3D retinal organoids from stem cells. The grant will enable travel to Kyoto, Japan, to learn from Ritsumeikan University scientists, with reciprocal visits planned. The work aims to improve cone synapse function for potential transplantation.Research to Prevent BlindnessResearch to Prevent Blindness Expands Career Development AwardResearch to Prevent Blindness increased its Career Development Award funding to $350,000 per grantee and expanded awardees to eight annually. The extra $50,000 is split between the last two years, and the program has awarded 219 grants with a 25:1 return on investment.